Wang Lixia, Ye Xiantao, Liu Yueyong, Wei Wenyi, Wang Zhiwei
The Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, China.
Oncotarget. 2014 Apr 30;5(8):2000-15. doi: 10.18632/oncotarget.1859.
FBW7 (F-box and WD repeat domain-containing 7) or Fbxw7 is a tumor suppressor, which promotes the ubiquitination and subsequent degradation of numerous oncoproteins including Mcl-1, Cyclin E, Notch, c- Jun, and c-Myc. In turn, FBW7 is regulated by multiple upstream factors including p53, C/EBP-δ, EBP2, Pin1, Hes-5 and Numb4 as well as by microRNAs such as miR-223, miR-27a, miR-25, and miR-129-5p. Given that the Fbw7 tumor suppressor is frequently inactivated or deleted in various human cancers, targeting FBW7 regulators is a promising anti-cancer therapeutic strategy.
FBW7(含F-box和WD重复结构域7)或Fbxw7是一种肿瘤抑制因子,它能促进包括Mcl-1、细胞周期蛋白E、Notch、c-Jun和c-Myc在内的多种癌蛋白的泛素化及随后的降解。反过来,FBW7受包括p53、C/EBP-δ、EBP2、Pin1、Hes-5和Numb4等多种上游因子以及miR-223、miR-27a、miR-25和miR-129-5p等微小RNA的调控。鉴于Fbw7肿瘤抑制因子在各种人类癌症中经常失活或缺失,靶向FBW7调控因子是一种很有前景的抗癌治疗策略。